A randomized, double-blind, placebo-controlled, active comparator, one-week, cross-over, multicenter study to evaluate the efficacy, patient preference and experience of one-daily, intranasal administration of 110 mcg fluticasone furoate nasal spray and 200mcg fluticasone propionate nasal spray in adult subjects with seasonal allergic rhinitis (FFU105924).

Trial Profile

A randomized, double-blind, placebo-controlled, active comparator, one-week, cross-over, multicenter study to evaluate the efficacy, patient preference and experience of one-daily, intranasal administration of 110 mcg fluticasone furoate nasal spray and 200mcg fluticasone propionate nasal spray in adult subjects with seasonal allergic rhinitis (FFU105924).

Completed
Phase of Trial: Phase IV

Latest Information Update: 13 Dec 2016

At a glance

  • Drugs Fluticasone furoate; Fluticasone propionate
  • Indications Seasonal allergic rhinitis
  • Focus Therapeutic Use
  • Sponsors GlaxoSmithKline
  • Most Recent Events

    • 01 Apr 2010 Results reported in the Annals of Allergy, Asthma & Immunology.
    • 30 Oct 2007 Status changed from recruiting to in progress.
    • 11 Oct 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top